CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
about
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationA type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors.Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma.The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.Trial Watch: Adoptive cell transfer for anticancer immunotherapy.Adoptive T-cell transfer in melanoma.Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response.Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice.Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells.S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.
P2860
Q28068378-56AB4A95-7ABA-4200-A37B-A161939EF26FQ33789317-F88AC544-30F4-4392-9466-8F4513A98405Q35130794-42C9DC8D-15A6-410B-A54B-86421973F31DQ36716083-D9BC2A76-9965-4E27-9EC6-946D9A4AA93BQ36883892-236B5A88-7BAF-4D2C-A1D5-1C84FD9750B5Q36887833-D23A72F8-0D31-41F4-8029-315E607B501CQ38068968-88B75CD4-B8F4-4E20-978F-5D663A21A08BQ38176613-D1333488-AD1F-43BC-9F09-B018A4484790Q38208309-BC2B3474-4F2C-402B-BF9D-23671CA27B15Q40605540-94F39221-BD40-455F-9AFA-D1BC9A7B0F29Q42003336-60ED3ADD-932C-411B-B4F3-BAB3E7A2373DQ48259591-60D4E5D6-331B-4CF9-BB38-ED346E8D8F80Q51138159-0E26BB48-0C56-4BED-A884-DC67FAB732D3
P2860
CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CD8 T cell priming in the pres ...... s for adoptive T cell therapy.
@en
CD8 T cell priming in the pres ...... s for adoptive T cell therapy.
@nl
type
label
CD8 T cell priming in the pres ...... s for adoptive T cell therapy.
@en
CD8 T cell priming in the pres ...... s for adoptive T cell therapy.
@nl
prefLabel
CD8 T cell priming in the pres ...... s for adoptive T cell therapy.
@en
CD8 T cell priming in the pres ...... s for adoptive T cell therapy.
@nl
P2093
P50
P356
P1476
CD8 T cell priming in the pres ...... ts for adoptive T cell therapy
@en
P2093
Agnes Le Bon
Aizea Morales-Kastresana
Ana Larraga
Diego Alignani
Hanspeter Pircher
Ignacio Melero
Iranzu Gonzalez
Jesus Prieto
Salvador Martín-Algarra
P304
P356
10.4049/JIMMUNOL.1102495
P407
P50
P577
2012-08-27T00:00:00Z